Journal of Emerging Research in Cancer Pharmacotherapy

The Journal of Emerging Research in Cancer Pharmacotherapy (JERCP) is a peer-reviewed, open-access journal dedicated to the advancement of pharmacological sciences in the field of oncology. The journal serves as a platform for researchers, clinicians, pharmacists, and healthcare professionals to share original research, reviews, case studies, and innovations focused on cancer drug development, therapy optimization, pharmacogenomics, and clinical pharmacology in oncology care.

We emphasize translational research that bridges laboratory findings with clinical applications in cancer pharmacotherapy. The journal welcomes contributions that address new therapeutic strategies, drug resistance, targeted therapies, personalized medicine, and supportive care in oncology.

Scope of the Journal:

JERCP invites original manuscripts in areas including but not limited to:

• Anticancer drug development and discovery
• Pharmacokinetics and pharmacodynamics of oncology drugs
• Targeted and immunotherapies
• Cancer pharmacogenomics and precision oncology
• Adverse effects and toxicity management in chemotherapy
• Oncology clinical trials and real-world studies
• Herbal and complementary cancer therapies
• Supportive and palliative pharmacotherapy in oncology

Key Features

• Double-blind peer review for objective assessment
• Fast-track publication with high editorial standards
• Global editorial board of oncology experts
• Open access to enhance research visibility and citations

Call for Papers

Researchers and practitioners are invited to submit high-quality manuscripts for upcoming issues. Join us in shaping the future of cancer pharmacotherapy research.

Stay Updated

Subscribe to receive journal updates, publication alerts, and special issue announcements.